Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
Abstract With the in-depth exploration on cancer therapeutic nanovaccines, increasing evidence shows that the poor delivery of nanovaccines to lymphoid organs has become the culprit limiting the rapid induction of anti-tumor immune response. Unlike the conventional prophylactic vaccines that mainly...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c8efa55ab0ae4d62b5de991db51d14d5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|